chemotherapy/fatigue

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of pharmaceutical chemistry and formulation. More particularly, it concerns the use of an effective amount of riboflavin and amino acids, in any combination, in the alleviation of the

The sequence listing in the file named "67858o707005.txt" having a size of 332,004 bytes that was created Nov. 23, 2009 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in

FIELD OF THE INVENTION The present invention provides an improved means for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstenediol (AED) and androstenetriol (AET). The

TECHNICAL FIELD This invention relates to a method for diagnosing and treating subacute myocarditis, i.e. cardiac dysfunction by electrocardiographic monitoring. BACKGROUND ART The medical community now recognizes a condition of unknown cause that is referred to as chronic fatigue syndrome. The role

TECHNICAL FIELD This invention relates to a method for diagnosing and treating a previously unrecognizable subacute cardiac dysfunction by electrocardiographic monitoring. BACKGROUND ART The medical community now recognizes a condition of unknown cause that is referred to as chronic fatigue

CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage of International Patent Application No. PCT/CN2013/001113, filed on Sep. 22, 2013 and entitled TRADITIONAL CHINESE MEDICINE COMBINATION FOR REGULATING IMMUNE FUNCTION AND PREPARATION METHOD THEREFOR, which claims the

TECHNICAL FIELD The present invention relates to a traditional Chinese medicine composition for regulating immunity and a preparation method thereof. BACKGROUND The immune system is a self defense mechanism to protect the body, and plays an important role in the occurrence, development, and

TECHNICAL FIELD The present invention relates to the field of therapeutic uses for erythropoietin, and more particularly, to treating subjects with a recombinant erythropoietin prepared from an Apa I human genomic DNA fragment, including recombinant erythropoietin expressed in transformed baby

FIELD OF THE INVENTION The present invention provides an improved means for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstenediol (AED) and androstenetriol (AET). BACKGROUND

BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical

The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the